Quick Answer
TANDEM DIABETES CARE INC reported Operating Income of -$187.26 million for fiscal year 2025.
TANDEM DIABETES CARE INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$187.26M | -88.9% |
| 2024 | -$99.13M | +57.5% |
| 2023 | -$233.23M | -151.2% |
| 2022 | -$92.85M | -509.9% |
| 2021 | $22.65M | +384.7% |
| 2020 | -$7.96M | +52.4% |
| 2019 | -$16.72M | +62.5% |
| 2018 | -$44.63M | +29.1% |
| 2017 | -$62.94M | +19.4% |
| 2016 | -$78.05M | -13.1% |
| 2015 | -$69.00M | +8.8% |
| 2014 | -$75.66M | -53.1% |
| 2013 | -$49.43M | -49.6% |
| 2012 | -$33.05M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$22.86M | +12.4% | +55.9% |
| June 30, 2025 | -$51.81M | -68.4% | +57.1% |
| March 31, 2025 | -$120.88M | -190.0% | -363.3% |
| September 30, 2024 | -$26.09M | +17.3% | +15.2% |
| June 30, 2024 | -$30.77M | +20.7% | +26.2% |
| March 31, 2024 | -$41.68M | +67.4% | -32.1% |
| September 30, 2023 | -$31.55M | +33.6% | +18.7% |
| June 30, 2023 | -$38.81M | -217.1% | +69.6% |
- TANDEM DIABETES CARE INC showed a decrease of -88.9% in Operating Income compared to the prior fiscal year.
- Over the 2012–2025 period, TANDEM DIABETES CARE INC’s operating income has declined by 466.6% (from -$33.05 million to -$187.26 million).
- The most recent figure is from TANDEM DIABETES CARE INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: